Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2026-05-24 @ 1:05 PM
Study NCT ID:
NCT05859334
Status:
RECRUITING
Last Update Posted:
2025-12-24
First Post:
2023-05-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
NCI-2023-03776
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None